Allergic diseases diagnosis and treatment
2024 Activity Indicators
- 3 national public competitive projects led: ISCIII
- 5 private projects led
- 15 clinical studies led
- 19 publications
- IF: 105.70
- Q1 publications: 16 (84%)
- D1 publications: 2 (11%)
- 1 award for quality in care and research in Allergology
- Evaluators from medical agencies and societies: 4 researchers
- Members of editorial comittees: 2 researchers
- 7 visitors and 10.7 months of stay:
- Polytechnic University of Madrid
- Sant Joan de Deu Hospital
- University Hospital of Santiago de Chile (Chile)
- Jimenez Diaz Foundation
- Princess University Hospital
- Txagorrithu Hospital, Vitoria
- Elche Hospital
Milestones
- Certification as a Center of Excellence in Allergology by the World Allergy Organization.
- Certification as a Multidisciplinary Unit of Excellence in Severe Asthma of High Complexity by SEPAR and SEAIC.
- Participation as a research group in the competitive public project (ISCIII) - Fortalece (FORT23/00046): Innovative Therapies for Personalized and Precision Medicine in Health Challenges.
- Inclusion of the research project on allergy to beta-lactam antibiotic drugs (PROA-ALERGIA) in the PROA of infectious diseases.
- Publication of the validation of the environmental exposure chamber for the study of respiratory allergy due to grass pollen.
Bibliometrics
| Articles | Accum. FI | Mean FI | Articles Q1 or Q2 | % in Q1 or Q2 | Articles D1 | % in D1 | |
|---|---|---|---|---|---|---|---|
| 2020 | 17 | 48.97 | 2.88 | 8 | 47 | 1 | 6 |
| 2021 | 17 | 93.25 | 5.49 | 15 | 88 | 2 | 12 |
| 2022 | 12 | 88.70 | 9.86 | 8 | 66,67 | 1 | 8,33 |
| 2023 | 36 | 237.52 | 7.20 | 32 | 89 | 5 | 14 |
| 2024 | 19 | 105.70 | 5.87 | 18 | 95 | 2 | 11 |
| 101 | 574.14 | 6.26 | 81 | 80 | 11 | 11 |
* Only original articles, editorials, guidelines and reviews
Networks and alliances
-
-
-
-
-
-
- Red Española de Mastocitosis